Splenic thrombosis in three patients with moderate hyperhomocysteinemia, low folate and the C677T variant of the methylenetetrahydrofolate reductase (MTHFR) gene

Ioannis Starakis; Athina Mougiou; Lydia Leonidou; Dimitrios Siagris; Chrysoula Karatza

doi:10.1160/TH05-06-1333

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2005; 94(06): 1333-1334
DOI: 10.1160/TH05-06-1333

Case Report

Schattauer GmbH

Splenic thrombosis in three patients with moderate hyperhomocysteinemia, low folate and the C677T variant of the methylenetetrahydrofolate reductase (MTHFR) gene

Ioannis Starakis

¹ Department of Internal Medicine

,

Athina Mougiou

² Department of Haematology and Transfusion, Patras University Hospital, Rion, Patras, Greece

,

Lydia Leonidou

¹ Department of Internal Medicine

,

Dimitrios Siagris

¹ Department of Internal Medicine

,

Chrysoula Karatza

¹ Department of Internal Medicine

› Author Affiliations

Abstract

Full Text

References

References
1 Andres E, Pflumio F, Knab MC. et al Splenic thrombosis and celiac disease: a fortuitous association?. Presse Med 2000; 29: 1933-4.
2 den Heijer M, Koster T, Blom HJ. et al Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996; 334: 759-62.
3 Selhub J, Jacques PF, Wilson PW. et al Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993; 270: 2693.
4 Ubbink JR, Vermaak WJ, van der Merwe A. et al Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr 1993; 57: 47.
5 Durand P, Prost M, Blache D. Pro-thrombotic effects of a folic acid deficient diet in rat platelets and macrophages related to elevated homocysteine and decreased n-3 polyunsaturated fatty acids. Atherosclerosis 1996; 121: 231-43.
6 Klerk M, Verhoef P, Clarke R. et al MTHFR 677C-->T polymorphism and risk of coronary heart disease: A Meta-analysis. JAMA 2002; 288: 2023.
7 Salomon O, Steinberg DM, Zivelin A. et al Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism. Arterioscler Thromb Vasc Biol 1999; 19: 511-8.
8 Arruda VR, von Zuben PM, Chiaparini LC. et al The mutation Ala⁶⁷⁷Val in the methylenetetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis. Thromb Haemost 1997; 77: 818-21.
9 Kluijtmans LAJ, den Heijer M, Reitsma PH. et al Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep vein thrombosis. Thromb Haemost 1998; 79: 254-8.
10 Gemmati D, Serino ML, Trivellato C. et al C677T substitution in the methylenetetrahydrofolate reductase gene as a risk factor for venous thrombosis and arterial disease in selected patients. Haematologica 1999; 84: 824-8.
11 Guttormsen AB, Ueland PM, Nesthus I. et al Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (40 βmol/liter). The Hordaland homocysteine study. J Clin Invest 1996; 98: 2174-83.
12 Malinow MR, Nieto FJ, Kruger WD. et al The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes. Arterioscler Thromb Vasc Biol 1997; 17: 1157-62.
13 Kang S-S, Zhou J, Wong PWK. et al Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet 1988; 43: 414-21.